Accéder au contenu
Merck
Toutes les photos(1)

Key Documents

View All Documentation

856707C

Avanti

17:1 Lyso PE

1-(10Z-heptadecenoyl)-sn-glycero-3-phosphoethanolamine, chloroform

Synonyme(s) :

1-heptadecenoyl-2-hydroxy-sn-glycero-3-phosphoethanolamine; PE(17:1(10Z)/0:0); 110699

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme
Toutes les photos(1)

About This Item

Formule empirique (notation de Hill):
C22H44NO7P
Numéro CAS:
1246298-09-8
Poids moléculaire :
465.56
Code UNSPSC :
12352211
Nomenclature NACRES :
NA.25

Pureté

>99% (LPE; may contain up to 10% of the 2-LPE isomer, TLC)

Forme

liquid

Conditionnement

pkg of 1 × 1 mL (856707C-5mg)

Fabricant/nom de marque

Avanti Research™ - A Croda Brand 856707C

Concentration

5 mg/mL (856707C-5mg)

Type de lipide

cardiolipins
phospholipids

Conditions d'expédition

dry ice

Température de stockage

−20°C

Chaîne SMILES 

O[C@](COP([O-])(OCC[NH3+])=O)([H])COC(CCCCCCCC/C=C\CCCCCC)=O

Conditionnement

5 mL Clear Glass Sealed Ampule (856707C-5mg)

Informations légales

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Souvent commandé avec ce produit

Réf. du produit
Description
Tarif

SMB00506

1-Heptadecanoyl-rac-glycerol, ≥98% (HPLC)

830756P

17:0 PE, Avanti Research™ - A Croda Brand

850103P

17:1 Lyso PI, 1-(10Z-heptadecenoyl)-2-hydroxy-sn-glycero-3-phospho-(1′-myo-inositol) (ammonium salt), powder

855676P

17:0 Lyso PC, Avanti Research™ - A Croda Brand

858127C

17:1 Lyso PG, 1-(10Z-heptadecenoyl)-sn-glycero-3-phospho-(1′-rac-glycerol) (sodium salt), chloroform

858141C

17:1 Lyso PS, 1-(10Z-heptadecenoyl)-2-hydroxy-sn-glycero-3-[phospho-L-serine] (sodium salt), chloroform

858141P

17:1 Lyso PS, 1-(10Z-heptadecenoyl)-2-hydroxy-sn-glycero-3-[phospho-L-serine] (sodium salt), powder

860517P

C17 Ceramide (d18:1/17:0), Avanti Research™ - A Croda Brand

860585P

17:0 SM (d18:1/17:0), Avanti Research™ - A Croda Brand 860585P, powder

860640P

Sphingosine (d17:1), Avanti Research™ - A Croda Brand 860640P, powder

860903P

17:0-17:1-17:0 D5 TG, Avanti Research™ - A Croda Brand 860903P, powder

LM1000

12:0-13:0 PC, Avanti Research™ - A Croda Brand LM1000, methanol solution

LM4100

cholesterol (D7), Avanti Research™ - A Croda Brand LM4100, methanol solution

Pictogrammes

Skull and crossbonesHealth hazard
GHS06,GHS08

Mention d'avertissement

Danger

Classification des risques

Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 3 - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3

Organes cibles

Central nervous system, Liver,Kidney

Classe de danger pour l'eau (WGK)

WGK 3

Certificats d'analyse (COA)

Recherchez un Certificats d'analyse (COA) en saisissant le numéro de lot du produit. Les numéros de lot figurent sur l'étiquette du produit après les mots "Lot" ou "Batch".

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Peng Wu et al.
Chinese medicine, 15, 9-9 (2020-01-31)
Our previous clinical evidence suggested that the direct application of "Sanse powder" the main ingredient of "Yiceng" might represent an alternative treatment for knee osteoarthritis. However, the mechanism underlying its effect is poorly understood. In this study, we investigated the
Tsukasa Yagi et al.
Cancers, 12(1) (2020-01-01)
Ovarian cancer remains a highly lethal disease due to its late clinical presentation and lack of reliable early biomarkers. Protein-based diagnostic markers have presented limitations in identifying ovarian cancer. We tested the potential of phospholipids as markers of ovarian cancer
Biyu Hou et al.
Life sciences, 245, 117352-117352 (2020-02-02)
The depot-specific differences in lipidome of visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) reflect heterogeneity of white adipose tissue (WAT), which plays a central role in its distinct response to outside stimuli. However, the detailed lipidome of depot-specific
Jordon M Inloes et al.
Biochemistry, 57(39), 5759-5767 (2018-09-18)
Deleterious mutations in the serine hydrolase DDHD domain containing 1 (DDHD1) cause the SPG28 subtype of the neurological disease hereditary spastic paraplegia (HSP), which is characterized by axonal neuropathy and gait impairments. DDHD1 has been shown to display PLA1-type phospholipase

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique